Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study

P. Queirolo; B. Dozin; A. Morabito; B. Banelli; P. Piccioli; C. Fava; C. Leo; R. Carosio; S. Laurent; V. Fontana; P.F. Ferrucci; C. Martinoli; E. Cocorocchio; A. Battaglia; P.A. Ascierto; M. Capone; E. Simeone; F. De Galitiis; E. Pagani; G.C.A. Cappellini; P. Marchetti; M. Guida; S. Tommasi; M. Mandalà; B. Merelli; P. Quaglino; P. Fava; M. Guidoboni; M. Romani; F. Spagnolo; M.P. Pistillo

doi:10.3389/fimmu.2017.00386

Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study

P. Queirolo, B. Dozin, A. Morabito, B. Banelli, P. Piccioli, C. Fava, C. Leo, R. Carosio, S. Laurent, V. Fontana, P.F. Ferrucci, C. Martinoli, E. Cocorocchio, A. Battaglia, P.A. Ascierto, M. Capone, E. Simeone, F. De Galitiis, E. Pagani, G.C.A. CappelliniP. Marchetti, M. Guida, S. Tommasi, M. Mandalà, B. Merelli, P. Quaglino, P. Fava, M. Guidoboni, M. Romani, F. Spagnolo, M.P. Pistillo

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Frontiers in Immunology
Volume	8
Issue number	APR
DOIs	https://doi.org/10.3389/fimmu.2017.00386
Publication status	Published - 2017

Access to Document

10.3389/fimmu.2017.00386

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018397156&doi=10.3389%2ffimmu.2017.00386&partnerID=40&md5=e13c21762713d52d99a98f34be070795

Cite this

Queirolo, P., Dozin, B., Morabito, A., Banelli, B., Piccioli, P., Fava, C., Leo, C., Carosio, R., Laurent, S., Fontana, V., Ferrucci, P. F., Martinoli, C., Cocorocchio, E., Battaglia, A., Ascierto, P. A., Capone, M., Simeone, E., De Galitiis, F., Pagani, E., ... Pistillo, M. P. (2017). Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study. Frontiers in Immunology, 8(APR). https://doi.org/10.3389/fimmu.2017.00386

Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study. / Queirolo, P.; Dozin, B.; Morabito, A.; Banelli, B.; Piccioli, P.; Fava, C.; Leo, C.; Carosio, R.; Laurent, S.; Fontana, V.; Ferrucci, P.F.; Martinoli, C.; Cocorocchio, E.; Battaglia, A.; Ascierto, P.A.; Capone, M.; Simeone, E.; De Galitiis, F.; Pagani, E.; Cappellini, G.C.A.; Marchetti, P.; Guida, M.; Tommasi, S.; Mandalà, M.; Merelli, B.; Quaglino, P.; Fava, P.; Guidoboni, M.; Romani, M.; Spagnolo, F.; Pistillo, M.P.

In: Frontiers in Immunology, Vol. 8, No. APR, 2017.

Research output: Contribution to journal › Article › peer-review

Queirolo, P , Dozin, B , Morabito, A, Banelli, B, Piccioli, P, Fava, C, Leo, C, Carosio, R, Laurent, S, Fontana, V , Ferrucci, PF, Martinoli, C, Cocorocchio, E, Battaglia, A, Ascierto, PA , Capone, M , Simeone, E , De Galitiis, F, Pagani, E, Cappellini, GCA, Marchetti, P, Guida, M , Tommasi, S, Mandalà, M, Merelli, B, Quaglino, P, Fava, P, Guidoboni, M, Romani, M, Spagnolo, F & Pistillo, MP 2017, 'Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study', Frontiers in Immunology, vol. 8, no. APR. https://doi.org/10.3389/fimmu.2017.00386

Queirolo, P. ; Dozin, B. ; Morabito, A. ; Banelli, B. ; Piccioli, P. ; Fava, C. ; Leo, C. ; Carosio, R. ; Laurent, S. ; Fontana, V. ; Ferrucci, P.F. ; Martinoli, C. ; Cocorocchio, E. ; Battaglia, A. ; Ascierto, P.A. ; Capone, M. ; Simeone, E. ; De Galitiis, F. ; Pagani, E. ; Cappellini, G.C.A. ; Marchetti, P. ; Guida, M. ; Tommasi, S. ; Mandalà, M. ; Merelli, B. ; Quaglino, P. ; Fava, P. ; Guidoboni, M. ; Romani, M. ; Spagnolo, F. ; Pistillo, M.P. / Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study. In: Frontiers in Immunology. 2017 ; Vol. 8, No. APR.

@article{5a8be5c50b5a42dd80baa690d3361d91,

title = "Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study",

author = "P. Queirolo and B. Dozin and A. Morabito and B. Banelli and P. Piccioli and C. Fava and C. Leo and R. Carosio and S. Laurent and V. Fontana and P.F. Ferrucci and C. Martinoli and E. Cocorocchio and A. Battaglia and P.A. Ascierto and M. Capone and E. Simeone and {De Galitiis}, F. and E. Pagani and G.C.A. Cappellini and P. Marchetti and M. Guida and S. Tommasi and M. Mandal{\`a} and B. Merelli and P. Quaglino and P. Fava and M. Guidoboni and M. Romani and F. Spagnolo and M.P. Pistillo",

note = "Export Date: 6 March 2018",

year = "2017",

doi = "10.3389/fimmu.2017.00386",

language = "English",

volume = "8",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media S.A.",

number = "APR",

}

TY - JOUR

T1 - Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study

AU - Queirolo, P.

AU - Dozin, B.

AU - Morabito, A.

AU - Banelli, B.

AU - Piccioli, P.

AU - Fava, C.

AU - Leo, C.

AU - Carosio, R.

AU - Laurent, S.

AU - Fontana, V.

AU - Ferrucci, P.F.

AU - Martinoli, C.

AU - Cocorocchio, E.

AU - Battaglia, A.

AU - Ascierto, P.A.

AU - Capone, M.

AU - Simeone, E.

AU - De Galitiis, F.

AU - Pagani, E.

AU - Cappellini, G.C.A.

AU - Marchetti, P.

AU - Guida, M.

AU - Tommasi, S.

AU - Mandalà, M.

AU - Merelli, B.

AU - Quaglino, P.

AU - Fava, P.

AU - Guidoboni, M.

AU - Romani, M.

AU - Spagnolo, F.

AU - Pistillo, M.P.

N1 - Export Date: 6 March 2018

PY - 2017

Y1 - 2017

U2 - 10.3389/fimmu.2017.00386

DO - 10.3389/fimmu.2017.00386

M3 - Article

VL - 8

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - APR

ER -